Controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: study protocol for a randomised controlled trial
Introduction Multimodal anticancer therapies greatly damage the fertility of breast cancer patients, which raises urgent demand for fertility preservation. The standard options for fertility preservation are oocyte and embryo cryopreservation; both require controlled ovarian hyperstimulation (COH)....
Saved in:
Main Authors: | Ping Li, Kun Wang, Qi Fan, Peng Sun, Yuhua Shi, Yanqiu Xie, Weifen Deng, Jiajing Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/1/e083943.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
by: Creticus P. Marak, et al.
Published: (2013-01-01) -
Ovarian hyperstimulation syndrome. A case report
by: Práxedes de Regla Rojas Quintana, et al.
Published: (2024-11-01) -
Spontaneous Ovarian Hyperstimulation Syndrome in a Triplet Pregnancy
by: Nisha Rani Agrawal, et al.
Published: (2012-01-01) -
Symptomatic Isolated Pleural Effusion as an Atypical Presentation of Ovarian Hyperstimulation Syndrome
by: Christine M. Mullin, et al.
Published: (2011-01-01) -
Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2013-12-01)